Updated Jul 16, 2026
Young Matthew P. has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Based on the provided SEC filing context (as of 2026-06-22), Matthew P. Young is associated with CytomX Therapeutics, Inc. as an insider. The exact role (e.g., officer, director, or beneficial owner) is not specified in the given context. No additional verifiable biographical details are confirmed here; a fuller profile would require direct SEC filing data or company disclosures.
| Role | Insider |
|---|---|
| Notability | 20/100 |
Based on the provided SEC filing context (as of 2026-06-22), Matthew P. Young is associated with CytomX Therapeutics, Inc. as an insider. The exact role (e.g., officer, director, or beneficial owner) is not specified in the given context. No additional verifiable biographical details are confirmed here; a fuller profile would require direct SEC filing data or company disclosure…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Young Matthew P. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.